Protein kinase C delta enhances the diagnostic performance of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Protein kinase C delta enhances the diagnostic performance of hepatocellular carcinoma

Published:2024-02-15 Issue:2 Volume:29 Page:55-67
ISSN:1354-750X
Container-title:Biomarkers
language:en
Short-container-title:Biomarkers

Author:

Nakagawa Chika¹,Oikawa Tsunekazu¹^ORCID,Yamada Kohji²^ORCID,Tsubota Akihito³^ORCID,Saeki Chisato¹,Katagiri Kuniko²,Tago Naoko²,Kamioka Hiroshi¹²,Ueda Kaoru¹,Haruki Koichiro⁴,Furukawa Kenei⁴,Nakano Masanori¹,Torisu Yuichi¹,Ikegami Toru⁴,Yoshida Kiyotsugu²^ORCID,Saruta Masayuki¹

Affiliation:

1. Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan

2. Department of Biochemistry, The Jikei University School of Medicine, Tokyo, Japan

3. Project Research Units, Research Center for Medical Science, The Jikei University School of Medicine, Tokyo, Japan

4. Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan

Funder

the Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/1354750X.2024.2312990

Reference57 articles.

1. α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C

2. Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study

3. The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study

4. Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

5. Hepatocellualar Carcinoma Serum Markers